These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9690406)

  • 1. Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group.
    Straus WL; Qazi SA; Kundi Z; Nomani NK; Schwartz B
    Lancet; 1998 Jul; 352(9124):270-4. PubMed ID: 9690406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan.
    Catchup Study Group
    Arch Dis Child; 2002 Feb; 86(2):113-8. PubMed ID: 11827905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics for community-acquired pneumonia in children.
    Lodha R; Kabra SK; Pandey RM
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD004874. PubMed ID: 23733365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial.
    Sadruddin S; Khan IUH; Fox MP; Bari A; Khan A; Thea DM; Khan A; Khan I; Ahmad I; Qazi SA
    Clin Infect Dis; 2019 Jul; 69(3):397-404. PubMed ID: 30596964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of 3-day amoxycillin vs. 5-day co-trimoxazole in the treatment of non-severe pneumonia in children aged 2-59 months of age: a multi-centric open labeled trial.
    Awasthi S; Agarwal G; Singh JV; Kabra SK; Pillai RM; Singhi S; Nongkynrih B; Dwivedi R; More VB; Kulkarni M; Niswade AK; Bharti B; Ambast A; Dhasmana P;
    J Trop Pediatr; 2008 Dec; 54(6):382-9. PubMed ID: 18611959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan.
    Hazir T; Qazi SA; Bin Nisar Y; Maqbool S; Asghar R; Iqbal I; Khalid S; Randhawa S; Aslam S; Riaz S; Abbasi S
    Arch Dis Child; 2007 Apr; 92(4):291-7. PubMed ID: 16547082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children.
    Campbell H; Byass P; Forgie IM; O'Neill KP; Lloyd-Evans N; Greenwood BM
    Lancet; 1988 Nov; 2(8621):1182-4. PubMed ID: 2903386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial.
    Soofi S; Ahmed S; Fox MP; MacLeod WB; Thea DM; Qazi SA; Bhutta ZA
    Lancet; 2012 Feb; 379(9817):729-37. PubMed ID: 22285055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial.
    Bari A; Sadruddin S; Khan A; Khan Iu; Khan A; Lehri IA; Macleod WB; Fox MP; Thea DM; Qazi SA
    Lancet; 2011 Nov; 378(9805):1796-803. PubMed ID: 22078721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.
    Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW
    Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).
    Asghar R; Banajeh S; Egas J; Hibberd P; Iqbal I; Katep-Bwalya M; Kundi Z; Law P; MacLeod W; Maulen-Radovan I; Mino G; Saha S; Sempertegui F; Simon J; Santosham M; Singhi S; Thea DM; Qazi S;
    BMJ; 2008 Jan; 336(7635):80-4. PubMed ID: 18182412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic strategies for developing countries: experience with acute respiratory tract infections in Pakistan.
    Qazi SA
    Clin Infect Dis; 1999 Feb; 28(2):214-8. PubMed ID: 10064229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan.
    Rasmussen ZA; Bari A; Qazi S; Rehman G; Azam I; Khan S; Aziz F; Rafi S; Roghani MT; Iqbal I; Nagi AG; Hussain W; Bano N; van Latum LJ; Khan M;
    Bull World Health Organ; 2005 Jan; 83(1):10-9. PubMed ID: 15682244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial.
    Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group
    Lancet; 2002 Sep; 360(9336):835-41. PubMed ID: 12243918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.
    Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA;
    Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial.
    Awasthi S; Agarwal G; Kabra SK; Singhi S; Kulkarni M; More V; Niswade A; Pillai RM; Luke R; Srivastava NM; Suresh S; Verghese VP; Raghupathy P; Lodha R; Walter SD
    PLoS One; 2008 Apr; 3(4):e1991. PubMed ID: 18431478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expanding role of co-trimoxazole in developing countries.
    Church JA; Fitzgerald F; Walker AS; Gibb DM; Prendergast AJ
    Lancet Infect Dis; 2015 Mar; 15(3):327-39. PubMed ID: 25618179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau.
    Garly ML; Balé C; Martins CL; Whittle HC; Nielsen J; Lisse IM; Aaby P
    BMJ; 2006 Dec; 333(7581):1245. PubMed ID: 17060336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community case management of fast-breathing pneumonia with 3 days oral amoxicillin vs 5 days cotrimoxazole in children 2-59 months of age in rural Pakistan: A cluster randomized trial.
    Ahmed S; Ariff S; Muhammed S; Rizvi A; Ahmed I; Soofi SB; Bhutta ZA
    J Glob Health; 2022 Dec; 12():04097. PubMed ID: 36579494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia.
    O'Doherty B; Dutchman DA; Pettit R; Maroli A
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():73-81. PubMed ID: 9484876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.